摘要
目的:探讨沐舒坦雾化吸入辅助治疗婴幼儿肺炎的效果。方法:将87例婴幼儿肺炎随机分成两组,两组均予常规抗感染等治疗,治疗组加用沐舒坦雾化吸入,对照组用α-靡蛋白酶、地塞米松和庆大霉素雾化吸入。对两组的咳嗽、痰鸣、气促、肺部湿罗音的消失时间及住院时间进行比较。结果:使用沐舒坦雾化吸入的治疗组在治疗咳嗽、痰鸣、肺部湿罗音消失时间方面比对照组短(P<0.05)。结论:沐舒坦雾化吸入可提高婴幼儿肺炎治疗效果,尤其祛痰和减少肺部湿性罗音的效果较好。
Objective： To investigate the clinical therapeutic effect of mucosolvan nebulization in infants with bronchopneumonia. Method： 87 infants were randomly divided into observation group and control group. Regular treatment were given to control group, meanwhile, based on regular treatment, the infants in observation group were also received mucosolvan nebulization. Result：The disappearing time of cough , wheezy phlegm and wheezy sound in lung in observation group were shorten than in control group { P 〈 0. 05 ）. Conclusion： Mucosolvan nebulization can raise clinical therapeutic effect for bronchopneumonia in in- fants with bronchopneumonia, especially in eliminating phlegm and disappearing of wheezy sound in lung.
出处
《河北医学》
CAS
2007年第2期196-198,共3页
Hebei Medicine
